Table 2.
Analyzed relative fatty acid compositions (%) of the dietary treatments and fat supplements, and fat content of the experimental diets and fat supplements (%), and intake of fatty acid (g/g fat) in the respective treatments
| Palmitoleic acid (PA) supplement1 | Fat supplements | |||||
|---|---|---|---|---|---|---|
| Fatty acid | 0% | 1% | 2% | 3% | Palmitoleic acid | Palm oil |
| C4:0 | 0.65 | 0.64 | 0.67 | 0.68 | 0.00 | 0.02 |
| C8:0 | 2.59 | 2.55 | 2.58 | 2.64 | 0.00 | 0.11 |
| C10:0 | 2.05 | 2.05 | 2.08 | 2.12 | 0.00 | 0.08 |
| C12:0 | 13.0 | 12.9 | 13.1 | 13.4 | 0.00 | 0.72 |
| C14:0 | 5.95 | 6.00 | 6.08 | 6.19 | 0.78 | 0.81 |
| C16:0 | 26.0 | 24.7 | 23.3 | 21.8 | 8.01 | 38.1 |
| C16:1n-7 | 0.28 | 3.78 | 7.35 | 10.7 | 87.0 | 0.12 |
| C16:1n-9 | 0.04 | 0.12 | 0.23 | 0.33 | 1.61 | 0.04 |
| C18:0 | 4.74 | 4.56 | 4.32 | 4.09 | 0.08 | 5.32 |
| C18:1n-7 | 0.58 | 0.57 | 0.53 | 0.53 | 0.27 | 0.63 |
| C18:1n-9 | 32.2 | 30.4 | 28.5 | 26.7 | 0.27 | 43.5 |
| C18:2n-6 | 9.78 | 9.39 | 8.95 | 8.59 | 0.05 | 9.30 |
| C18:3n-3 | 0.67 | 0.66 | 0.64 | 0.64 | 0.00 | 0.32 |
| SAFA2 | 55.7 | 57.3 | 52.9 | 51.7 | 9.02 | 45.8 |
| MUFA2 | 33.4 | 35.2 | 36.9 | 38.5 | 89.3 | 44.5 |
| PUFA2 | 10.7 | 10.3 | 9.82 | 9.45 | 0.18 | 9.65 |
| Fat percentage | 19.1 | 19.4 | 19.5 | 19.1 | 98.3 | 96.6 |
| Sum of fatty acids/100 g sample | 18.1 | 17.7 | 17.8 | 17.0 | 71.1 | 74.0 |
| Fatty acids as a percentage of total fat | 94.9 | 91.5 | 91.1 | 88.8 | 72.2 | 76.6 |
10% = milk replacer mixed with 3% palm oil and 0% palmitoleic acid; 1% = milk replacer mixed with 2% palm oil and 1% palmitoleic acid; 2% = milk replacer mixed with 1% palm oil and 2% palmitoleic acid; 3% = milk replacer mixed with 0% palm oil and 3% palmitoleic acid.
2SAFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, poly unsaturated fatty acids.